Mechanistic target of rapamycin (mTOR) regulates self-sustained quiescence, tumor indolence, and late clinical metastasis in a Beclin-1-dependent manner

Carole Nicco(Centre National de la Recherche Scientifique), Thierry Tchénio(Centre National de la Recherche Scientifique)
Cell Cycle
September 19, 2022
Cited by 6


Related Papers